FindTrial
Sign In

The clinical study of probiotics influences on gut microbiota's composition and function of patients with non-alcoholic fatty liver disease

The clinical study of probiotics influences on gut microbiota's composition and function of patients with non-alcoholic fatty liver disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051916
Enrollment
Unknown
Registered
2021-10-09
Start date
2021-10-07
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease, NAFLD

Interventions

Control group:Diet, exercise
Experimental group:Probiotics

Sponsors

Chongqing Changshou District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Ultrasound confirmed fatty liver; 2.Aged 20 to 60 years.

Exclusion criteria

Exclusion criteria: 1.Fatty liver caused by alcohol and other causes; 2.Pregnancy and combined heart, liver, lung, kidney, cerebrovascular, endocrine and other primary diseases; 3.Mental patients; 4.People with allergic constitution and multiple drug allergies; 5.Obvious liver damage (serum transaminase > 2 times the upper limit of normal); 6.Patients who have taken antibiotics in the past 3 months; 7.Drug-treated patients.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;—

Secondary

MeasureTime frame
Endotoxin;Aspartic transaminase;Glutamic-pyruvic transaminase;Insulin;Fasting blood sugar;Low density lipoprotein cholesterin;High density lipoprotein cholesterin;Body weight;Abdominal circumference;Controlled decay index;—

Countries

China

Contacts

Public ContactLiu Jianping

Chongqing Changshou District People's Hospital

16968306@qq.com+86 17784350660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026